ROTABLATOR ROTATIONAL ANGIOPLASTY SYSTEM WITH THE ROTALINK EXCHANGEABLE CATHETER— 510(k) K993648

Substantially Equivalent

Boston Scientific Corporation Northwest Technology

FDA 510(k) clearance K993648 for ROTABLATOR ROTATIONAL ANGIOPLASTY SYSTEM WITH THE ROTALINK EXCHANGEABLE CATHETER, Substantially Equivalent on 1999-11-24. Applicant: Boston Scientific Corporation Northwest Technology.

Clearance details

Applicant
Boston Scientific Corporation Northwest Technology
Product code
Code MCW
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Redmond, WA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code MCW

product code MCW
Death
38
Injury
1,386
Malfunction
2,676
Other
2
Total
4,102

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.